Amgen shrugs off tough quarter, announces plans for new plant in North Carolina
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Tri-county region’s total farm revenue up 4.6% in 2020
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Highway 101 widening on tap for Ventura County
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen reports Q2 earnings decline
Amgen saw a 73% decline in net earnings in the second quarter of 2021, the company announced Aug. 3. Thousand Oaks-based Amgen, one of the world’s largest biotechnology companies, reported earnings per share of 81 cents for the quarter ended June 30, down from $3.05 per share in the same quarter last year. According to Read More →
With merger, ImmPact Bio plans growth and a move to LA
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Waste Management hauls rival into court over loss of Thousand Oaks contract
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dole down 9.4% in first day on NYSE
Westlake Village-based Dole is publicly traded once again, after raising $400 million in a July 30 initial public offering. The IPO was a bit of a letdown for Dole. The company priced its shares at $16 only to see them open at $15 and then drop to $14.50 by the end of the trading day, Read More →
